All Stories

  1. Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype–phenotype correlations

    Article • European Respiratory Journal, June 2024, European Respiratory Society (ERS)

    Henryk Mazurek

  2. Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial

    Article • The Lancet Respiratory Medicine, January 2024, Elsevier

    Henryk Mazurek

  3. Childhood asthma treatment based on indirect hyperresponsiveness test: Randomized controlled trial

    Article • Pediatric Pulmonology, June 2023, Wiley

    Henryk Mazurek

  4. Guidelines for asthma diagnosis and treatment Polish Society of Allergology, Polish Society of Lung Diseases and Polish Society of Family Medicine (STAN3T)

    Article • Alergologia Polska - Polish Journal of Allergology, January 2023, Termedia Sp. z.o.o.

    Henryk Mazurek

  5. The Effects of Gabapentin on Post-Operative Pain and Anxiety, Morphine Consumption and Patient Satisfaction in Paediatric Patients Following the Ravitch Procedure—A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial

    Article • Journal of Clinical Medicine, August 2022, MDPI AG

    Henryk Mazurek

  6. Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)

    Article • Healthcare, April 2022, MDPI AG

    Henryk Mazurek

  7. Risk Factors and Protective Factors against Ventilator-Associated Pneumonia—A Single-Center Mixed Prospective and Retrospective Cohort Study

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Henryk Mazurek

  8. Lung function from school age to adulthood in primary ciliary dyskinesia

    Article • European Respiratory Journal, March 2022, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  9. Plastic Bronchitis—A Serious Rare Complication Affecting Children Only after Fontan Procedure?

    Article • Journal of Clinical Medicine, December 2021, MDPI AG

    Henryk Mazurek

  10. Automatic Continuous Control of Cuff Pressure and Subglottic Secretion Suction Used Together to Prevent Pneumonia in Ventilated Patients—A Retrospective and Prospective Cohort Study

    Article • Journal of Clinical Medicine, October 2021, MDPI AG

    Henryk Mazurek

  11. Relationship Between Air Pollution and the Concentration of Nitric Oxide in the Exhaled Air (FeNO) in 8–9-Year-Old School Children in Krakow

    Article • International Journal of Environmental Research and Public Health, June 2021, MDPI AG

    Henryk Mazurek

  12. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6

    Article • Clinical & Experimental Immunology, June 2021, Oxford University Press (OUP)

    Henryk Mazurek

  13. Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis – a randomized trial

    Article • Journal of Cystic Fibrosis, January 2021, Elsevier

    Henryk Mazurek

  14. Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis

    Article • Journal of Cystic Fibrosis, January 2021, Elsevier

    Henryk Mazurek

  15. Reduced Exercise Tolerance Does Not Always Mean Bronchial Asthma

    Article • Pediatric Allergy Immunology and Pulmonology, December 2020, Mary Ann Liebert Inc

    Henryk Mazurek

  16. Estimation of Proinflammatory Factors in the Saliva of Adult Patients with Cystic Fibrosis and Dental Caries

    Article • Medicina, November 2020, MDPI AG

    Henryk Mazurek

  17. Are patients with lung cystic fibrosis at increased risk for severe and fatal COVID-19? Interleukin-6 as a predictor of COVID-19 outcome

    Article • Polish Archives of Internal Medicine, October 2020, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Henryk Mazurek

  18. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis

    Article • Mediators of Inflammation, March 2020, Hindawi Publishing Corporation

    Henryk Mazurek

  19. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

    Article • Journal of Cystic Fibrosis, March 2020, Elsevier

    Henryk Mazurek

  20. Acute Subglottic Laryngitis. Etiology, Epidemiology, Pathogenesis and Clinical Picture

    Article • Advances in respiratory medicine, October 2019, MDPI AG

    Henryk Mazurek

  21. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study

    Article • September 2019, Springer Science + Business Media

    Henryk Mazurek

  22. Time trends in diagnostic testing for primary ciliary dyskinesia in Europe

    Article • European Respiratory Journal, July 2019, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek, Professor Siobhan B Carr

  23. Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma

    Article • Advances in Dermatology and Allergology, January 2019, Termedia Sp. z.o.o.

    Henryk Mazurek

  24. Reference values for impulse oscillometry for children aged 3–18 years obtained using lambda-mu-sigma method – preliminary results

    Article • September 2018, European Respiratory Society (ERS)

    Henryk Mazurek

  25. Prevalence and Impact of Lung Resection in Primary Ciliary Dyskinesia: a cohort and nested case-control study

    Article • September 2018, European Respiratory Society (ERS)

    Henryk Mazurek

  26. A 2-year-old girl with chronic crackles after respiratory syncytial virus infection: a case report

    Article • Journal of Medical Case Reports, September 2018, Springer Science + Business Media

    Henryk Mazurek

  27. Lung function in patients with Primary Ciliary Dyskinesia: an iPCD Cohort study

    Article • European Respiratory Journal, July 2018, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  28. Seasonality of sputum eosinophilia in adolescents with asthma remission: effects of montelukast

    Article • Pediatric Allergy and Immunology, July 2018, Wiley

    Henryk Mazurek

  29. Polish Society of Alergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma

    Article • Alergologia Polska - Polish Journal of Allergology, January 2018, Termedia Sp. z.o.o.

    Henryk Mazurek

  30. Growth and nutritional status, and their association with lung function: a study from the international Primary Ciliary Dyskinesia Cohort

    Article • European Respiratory Journal, December 2017, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  31. Evolution of Primary Ciliary Dyskinesia (PCD) diagnostic testing in Europe

    Article • September 2017, European Respiratory Society (ERS)

    Henryk Mazurek

  32. Zasady stosowania komór inhalacyjnych u dzieci

    Article • Pediatria Polska, May 2017, Termedia Sp. z.o.o.

    Henryk Mazurek

  33. Hypersensitivity Pneumonitis in an 11-Year-Old Boy—A Case Report

    Article • Pediatric Allergy Immunology and Pulmonology, March 2017, Mary Ann Liebert Inc

    Henryk Mazurek

  34. The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  35. Standardy opieki Europejskiego Towarzystwa Mukowiscydozy: zarządzanie jakością w zakresie mukowiscydozy

    Article • Pediatria Polska, September 2016, Termedia Sp. z.o.o.

    Henryk Mazurek

  36. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast

    Article • Pulmonary Pharmacology & Therapeutics, August 2016, Elsevier

    Henryk Mazurek

  37. Macrolide antibiotics in respiratory diseases. Recommendations of the Polish Expert Group — AD 2015

    Article • Pneumonologia i Alergologia Polska, January 2016, MDPI AG

    Henryk Mazurek

  38. ReCOMmendations for management of Preschool ASthma for General Practitioners – COMPAS GP

    Article • Family Medicine & Primary Care Review, January 2016, Termedia Sp. z.o.o.

    Henryk Mazurek

  39. Factors related to changes in the quality of life among Polish adolescents and adults with cystic fibrosis over a 1-year period

    Article • Patient Preference and Adherence, December 2015, Taylor & Francis

    Henryk Mazurek

  40. Problems of Patients with Cystic Fibrosis during Transition to Adulthood

    Article • Advances in respiratory medicine, September 2015, MDPI AG

    Henryk Mazurek

  41. LATE-BREAKING ABSTRACT: Lung function in patients with primary ciliary dyskinesia (PCD): A multinational study

    Article • September 2015, European Respiratory Society (ERS)

    Dr Nicolaus Schwerk, Henryk Mazurek

  42. Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS

    Article • Journal of Cystic Fibrosis, December 2014, Elsevier

    Henryk Mazurek

  43. Evaluation of step-down therapy from an inhaled steroid to montelukast in childhood asthma

    Article • Allergologia et Immunopathologia, July 2014, Codon Publications

    Henryk Mazurek

  44. Distribution of Antibodies to Selected Antigens of Pseudomonas aeruginosa in Children and Young Adults with Cystic Fibrosis

    Article • Advances in respiratory medicine, June 2014, MDPI AG

    Henryk Mazurek

  45. A Pharmacokinetics and Safety Comparison of a Highly Concentrated Tobramycin Solution with TOBI

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, June 2014, Mary Ann Liebert Inc

    Henryk Mazurek

  46. Quality of life in patients with cystic fibrosis depending on the severity of the disease and method of its treatment

    Article • Postępy Higieny i Medycyny Doświadczalnej, May 2014, De Gruyter

    Henryk Mazurek

  47. Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis

    Article • Pediatric Pulmonology, January 2014, Wiley

    Henryk Mazurek

  48. Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

    Article • Thorax, June 2013, BMJ

    Henryk Mazurek

  49. Patient’s perception of the meaning of life in cystic fibrosis – its evaluation with respect to the stage of the disease and treatment

    Article • Postępy Higieny i Medycyny Doświadczalnej, October 2012, De Gruyter

    Henryk Mazurek

  50. Liprotamase Long-term Safety and Support of Nutritional Status in Pancreatic-insufficient Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, February 2012, Wolters Kluwer Health

    Henryk Mazurek

  51. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients

    Article • Journal of Cystic Fibrosis, December 2011, Elsevier

    Henryk Mazurek

  52. Is Prediction of the Allergic March Possible on the Basis of Nasal Cytology?

    Article • Advances in respiratory medicine, July 2010, MDPI AG

    Henryk Mazurek

  53. Regular vs prn nebulized treatment in wheeze preschool children

    Article • Allergy, September 2009, Wiley

    Henryk Mazurek

  54. A Formulation of Aerosolized Tobramycin (Bramitob??) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection

    Article • Pediatric Drugs, January 2007, Springer Science + Business Media

    Henryk Mazurek

  55. Input respiratory impedance measured by head generator in preschool children

    Article • Pediatric Pulmonology, January 2000, Wiley

    Henryk Mazurek

  56. Specificity and Sensitivity of Respiratory Impedance in Assessing Reversibility of Airway Obstruction in Children

    Article • CHEST Journal, April 1995, Elsevier

    Henryk Mazurek

  57. Persistent increased lung response to methacholine after normobaric hyperoxia in rabbits

    Article • Respiration Physiology, February 1995, Elsevier

    Henryk Mazurek

  58. Input respiratory impedance to estimate airway hyperreactivity in children: standard method versus head generator

    Article • European Respiratory Journal, March 1994, European Respiratory Society (ERS)

    Henryk Mazurek

  59. Low-frequency vs. High-frequency respiratory mechanics after methacholine challenge in artificially ventilated rabbits

    Article • Pediatric Pulmonology, November 1993, Wiley

    Henryk Mazurek